GET THE APP
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr Mark Sutherland is a Senior Experimental Officer at the Institute of Cancer Therapeutics, University of Bradford. After completing his MSc in Molecular Biology at the University of Stellenbosch, South Africa he worked for a few years as a school teacher and University Lecturer. He was offered a PhD at the Charite – Campus Benjamin Franklin, Berlin, Germany where he received his degree. He then worked for a number of years as a PDRA in Berlin in the field of immunotoxins. In 2005 he moved to the University of Bradford. In his current role he carries out research for a number a projects within the Institute, teach laboratory skills to MSc and PhD students, and lectures undergraduate and MSc students. His current research is in the field of integrins as a target for new anti-cancer drugs in prostate cancer and melanoma, as well as the role of sialyltransferases in neuroblastoma.
Dual/multi-integrin antagonism in prostate cancer and melanoma